Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.
Biomarkers
Immunogenicity
Pharmacokinetics (PK)
Cell-Based Assays
Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.
Biosimilars
Gene Therapy
Antibody Drug Conjugates (ADCs)
Immuno-oncology
Co-Hosted with GE Healthcare
The assessment of unwanted immunogenicity is a key parameter in the development process of biological protein drugs. In this webinar, BioAgilytix’s experts Dr. Arno Kromminga and Dr. Daniel Worms discuss aspects of when and how to use the Biacore™ T200 SPR System to obtain a deeper understanding of unwanted immunogenicity.
Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.
Quick links to our latest content offerings:
LinkedIn Company Updates
2 Days Agoview on linkedin
The wait is over: Critical Path Institute (C-Path) has released its Points to Consider document providing a comprehensive user guide for bioanalytical assay validation in support of clinical biomarker qualification in biological fluids. Our own Dr. Afshin Safavi contributed to this paper and we are thrilled to see consensus being established around best practice approaches for the development and qualification of clinical biomarkers, including considerations for sample collection, bioanalytical parameters to assess during assay validation, and the setting up of proper acceptance criteria. Access the full document here: https://lnkd.in/et4mMNq
2 Days Agoview on linkedin
“New aspects in regulated Bioanalysis” Workshop: Join PD Dr. Arno Kromminga & Dr. Lydia Michaut on 28 June in Munich, Germany as they cover new aspects in the understanding of immunogenicity including novel advanced medical therapies such as gene therapies. View the full workshop agenda here: https://bit.ly/2RilmZz and contact Soubhik Banerjee at soubhik.banerjee@bioagilytix.de to reserve your spot.
3 Days Agoview on linkedin
Our team is seeking a Director (GMP) to provide strategic and managerial oversight of #GMP bioanalytical operations at our U.S. headquarters in Durham, North Carolina. View the qualifications and apply today: https://lnkd.in/e_P72jB
June 14, 2019Your Questions About Immunogenicity Assessment of Gene Therapy Compounds Answered
June 4, 2019A History of Gene Therapy: Exploring Lessons Learned In Light of New Approvals
June 11, 2019BioAgilytix Welcomes Sean Blake to Leadership Team as Chief Information Officer
March 26, 2019BioAgilytix Announces Promotion of Corinna Fiorotti, Ph.D. to Scientific Officer and Key Accounts Director
May 9, 2018Evaluating the Immunogenicity of Antibody–drug Conjugates
April 16, 2018Strategies for Development and Validation of Neutralizing Antibody Assays Supporting Biosimilars
Services
Platforms
Choose a Location to learn more about the premier bioanalytical services and solutions available at each of our advanced laboratories in the USA and Europe.
